-Reuters
SELLAS Life Sciences Shares Tumble As Acute Myeloid Leukemia Trial Will Longer Than Anticipated
SELLAS Life Sciences Group Inc (NASDAQ:SLS) announced updates relating to its ongoing Phase 3 REGAL study for galinpepimut-S (GPS) in acute…